While U.S. cervical cancer rates have fallen by 70% since the 1950s thanks to the Pap test and national screening programs, the disease remains a leading killer of women in low- and middle-income countries for lack of access to screening and trained providers.
Kathleen Schmeler, M.D., professor of Gynecologic Oncology and Reproductive Medicine, is working change this. Her work to prevent and treat cervical cancer has taken...
Despite the fact that the human papillomavirus (HPV) vaccine has been available in the U.S. for over 10 years and remains the only vaccine...
A study from researchers at The University of Texas MD Anderson Cancer Center found that the prevalence of the types of oral human papillomavirus...
According to the Centers for Disease Control and Prevention, the human papillomavirus is responsible for roughly 33,700 new cancer cases each year, including cancers of the head and neck, the cervix, genitalia, anus and rectum. While there is a safe and effective vaccine available to prevent the majority of these cancers, incidence rates for HPV-related cancers continues to rise, increasing the need for new treatment approaches....
MD Anderson Cancer Center researchers, together with collaborators from Mozambique, Brazil and the U.S., have been awarded a $5.1 million...
In recent years, the surgical technique sentinel lymph node biopsy has allowed surgeons to more accurately determine how far cancer has spread...
Despite the availability of vaccines that could prevent the majority of cancers caused by the human papillomavirus (HPV), the incidence of...
In Texas, the number is even lower. Only 33% of Texas teens were up to date. That’s a lot of room for improvement.
Having spent the...
World Cancer Day is Saturday, Feb. 4. It’s the one singular initiative under which the entire world unites to fight cancer through prevention...
Cervical cancer is the fourth most common cancer among women worldwide and was responsible for approximately 266,000 deaths in 2012, according...